ResearcherPrinceton UniversityNo recent work listed

Matthew Joseph McBride

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9846-3385; OpenAlex author ID A5054707787; NIH RePORTER profile ID 12261495. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2022: 1 paper, 1 grant

Papers 1

Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. Co-author DOI 10.1016/j.medj.2021.12.008 ↗

Grants 1

Modulating one-carbon metabolism with diet and targeted inhibitors to treat cancer F32CA250190 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenyun Lu · 1 shared paper, 2022 · strength 0.12
- Paper Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. DOI 10.1016/j.medj.2021.12.008 ↗
Michel Nofal · 1 shared paper, 2022 · strength 0.12
- Paper Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. DOI 10.1016/j.medj.2021.12.008 ↗
Gaoyang Liang · 1 shared paper, 2022 · strength 0.12
- Paper Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. DOI 10.1016/j.medj.2021.12.008 ↗
Lifeng Yang · 1 shared paper, 2022 · strength 0.12
- Paper Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. DOI 10.1016/j.medj.2021.12.008 ↗
Serina Ng · 1 shared paper, 2022 · strength 0.12
- Paper Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. DOI 10.1016/j.medj.2021.12.008 ↗
Haiyong Han · 1 shared paper, 2022 · strength 0.12
- Paper Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. DOI 10.1016/j.medj.2021.12.008 ↗
Joshua D. Rabinowitz · 1 shared paper, 2022 · strength 0.12
- Paper Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. DOI 10.1016/j.medj.2021.12.008 ↗
Ronald M. Evans · 1 shared paper, 2022 · strength 0.12
- Paper Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. DOI 10.1016/j.medj.2021.12.008 ↗
Daniel D. Von Hoff · 1 shared paper, 2022 · strength 0.12
- Paper Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. DOI 10.1016/j.medj.2021.12.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.